CC
LLY icon

Callan Capital’s Eli Lilly LLY Stock Holding History

Callan Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.92M Buy
4,745
+645
+16% +$537K 0.29% 51
2024
Q4 		$3.17M Sell
4,100
-220
-5% -$182K 0.23% 61
2024
Q3 		$3.83M Buy
4,320
+377
+10% +$339K 0.27% 54
2024
Q2 		$3.57M Buy
3,943
+536
+16% +$429K 0.29% 54
2024
Q1 		$2.65M Buy
3,407
+579
+20% +$412K 0.23% 58
2023
Q4 		$1.65M Buy
2,828
+1,779
+170% +$1.04M 0.16% 71
2023
Q3 		$563K Buy
1,049
+247
+31% +$127K 0.06% 112
2023
Q2 		$376K Buy
802
+120
+18% +$50.3K 0.04% 127
2023
Q1 		$234K Sell
682
-130
-16% -$43.8K 0.03% 161
2022
Q4 		$297K Buy
+812
New +$288K 0.04% 145

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Callan Capital's LLY Position: Q1 2025 in Review

Callan Capital increased its Eli Lilly (LLY) stake by 16% in Q1 2025, buying an estimated $537K and bringing the position to 4,745 shares worth $3.92M. The position accounts for 0.29% of the portfolio, ranked #51.

Callan Capital first reported a position in LLY in Q4 2022 and has held it in 10 quarters since. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Callan Capital held 4,745 shares of Eli Lilly worth $3.92M as of Q1 2025.
  • Callan Capital bought 645 Eli Lilly shares in Q1 2025, an estimated $537K.
  • Eli Lilly made up 0.29% of Callan Capital's portfolio in Q1 2025, its #51 holding.
  • Callan Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 10 quarters since.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.